Newborns with low levels of vitamin D may be at increased risk for developing severe respiratory syncytial virus (RSV) infection with bronchiolitis during their first year of life, suggests a Dutch prospective birth cohort study.
Newborns with low levels of vitamin D may be at increased risk for developing severe respiratory syncytial virus (RSV) infection with bronchiolitis during their first year of life, suggests a Dutch prospective birth cohort study.
Researchers at Wilhelmina Children’s Hospital in Utrecht studied the relation between concentrations of 25-hydroxyvitamin D (25-OHD) in cord blood plasma and lower respiratory tract infection (LRTI) caused by RSV in 156 healthy neonates. They defined RSV LRTI on the basis of a daily log by parents of their child's LRTI symptoms and the simultaneous presence of RSV RNA in a nose-throat specimen.
Eighteen (12%) infants developed RSV LRTI during their first year. They had lower concentrations of 25-OHD than babies without RSV LRTI (65 nmol/L vs 84 nmol/L). Babies born with 25-OHD concentrations lower than 50 nmol/L were 6 times more likely to develop RSV LRTI during their first year than those with concentrations of 75 nmol/L or higher. Cord blood concentrations of 25-OHD were strongly associated with maternal vitamin D3 supplementation during pregnancy. The study was published online May 9 in Pediatrics.
Only 46% of women in the study cohort reported taking vitamin D supplements while they were pregnant.
Of the 156 neonates studied, 27% had 25-OHD concentrations below 50 nmol/L (inadequate), 27% had concentrations between 50 nmol/L and 74 nmol/L (considered inadequate by some experts), and 46% had concentrations of at least 74 nmol/L (adequate). Infants with concentrations in the controversial 50 nmol/L to 74 nmol/L range did not demonstrate increased risk of RSV LRTI.
Pregnant women should continue to follow expert guidelines on vitamin D intake pending further research, recommends senior investigator Louis Bont, MD. The US Institute of Medicine recommends 600 IU per day of vitamin D with an upper daily limit of 4,000 IU.
Balancing VTE and bleeding risks in gynecologic cancer surgeries
December 6th 2024A comprehensive analysis shows the benefits of thromboprophylaxis often outweigh the bleeding risks during gynecologic cancer procedures, though patient-specific risk factors are crucial for decision-making.
Read More
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More